Robert Langer, the David H. Koch Insitute Professor at MIT, has more than 800 pending and issued patents, which have been licensed to hundreds of companies, including medical device manufacturers. Langer, who will receive the 2013 MDEA Lifetime Achievement Award next month, has also launched more than two dozen start-ups based on the groundbreaking discoveries and advances he has made in fields including drug delivery, tissue engineering, nanotechnology, and personalized medicine.
“Our track record has been very good in terms of investors getting a good return on the companies we’ve started,” he says.
Langer is acutely aware of how difficult it is for today's medtech start-ups, which face hurdles including a tough funding environment and regulatory uncertainty. I spoke with him recently about what it takes to make it as a start-up these days.
Here's his formula:
Jamie Hartford is the managing editor of MD+DI.